Click for best price

RNA Drugs Market Size, Share 2022

Market Analysis and Insights: Global RNA Drugs Market

The global RNA Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global RNA Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global RNA Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global RNA Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global RNA Drugs market.

Global RNA Drugs Scope and Market Size

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2018 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

siRNA

ASO

miRNA

Nucleic Acid Aptamers

Segment by Application

Cancer

Diabetes

Tuberculosis

Cardiovascular Diseases

Others

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

Pfizer

Roche

Sanofi-Aventis

Abbott Laboratories

Arrowhead Pharmaceuticals

Benitec Biopharma

Calimmune Inc

Dicerna

Gradalis

Quark

RXi

Senesco

Silence Therapeutics

Silenseed

Tekmira

Alnylam Pharmaceuticals

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes RNA Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of RNA Drugs, with price, sales, revenue, and global market share of RNA Drugs from 2019 to 2022.

Chapter 3, the RNA Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the RNA Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the RNA Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of RNA Drugs.

Chapter 13, 14, and 15, to describe RNA Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 RNA Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes	Report Details
Report Title	Global RNA Drugs Market Research Report 2023
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2021
Forecast Year	2029
Number of Pages	100 Pages
Customization Available	Yes, the report can be customized as per your need.

1 RNA Drugs Market Overview
1.1 Product Overview and Scope of RNA Drugs
1.2 RNA Drugs Segment by Type
1.2.1 Global RNA Drugs Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 siRNA
1.2.3 ASO
1.2.4 miRNA
1.2.5 Nucleic Acid Aptamers
1.3 RNA Drugs Segment by Application
1.3.1 Global RNA Drugs Sales Comparison by Application: (2023-2030)
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Global RNA Drugs Market Size Estimates and Forecasts
1.4.1 Global RNA Drugs Revenue 2018-2030
1.4.2 Global RNA Drugs Sales 2018-2030
1.4.3 RNA Drugs Market Size by Region: 2018 Versus 2022 Versus 2030
2 RNA Drugs Market Competition by Manufacturers
2.1 Global RNA Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global RNA Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global RNA Drugs Average Price by Manufacturers (2018-2023)
2.4 Manufacturers RNA Drugs Manufacturing Sites, Area Served, Product Type
2.5 RNA Drugs Market Competitive Situation and Trends
2.5.1 RNA Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest RNA Drugs Players Market Share by Revenue
2.5.3 Global RNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 RNA Drugs Retrospective Market Scenario by Region
3.1 Global RNA Drugs Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global RNA Drugs Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America RNA Drugs Market Facts & Figures by Country
3.3.1 North America RNA Drugs Sales by Country
3.3.2 North America RNA Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe RNA Drugs Market Facts & Figures by Country
3.4.1 Europe RNA Drugs Sales by Country
3.4.2 Europe RNA Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific RNA Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific RNA Drugs Sales by Region
3.5.2 Asia Pacific RNA Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America RNA Drugs Market Facts & Figures by Country
3.6.1 Latin America RNA Drugs Sales by Country
3.6.2 Latin America RNA Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa RNA Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa RNA Drugs Sales by Country
3.7.2 Middle East and Africa RNA Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global RNA Drugs Historic Market Analysis by Type
4.1 Global RNA Drugs Sales Market Share by Type (2018-2023)
4.2 Global RNA Drugs Revenue Market Share by Type (2018-2023)
4.3 Global RNA Drugs Price by Type (2018-2023)
5 Global RNA Drugs Historic Market Analysis by Application
5.1 Global RNA Drugs Sales Market Share by Application (2018-2023)
5.2 Global RNA Drugs Revenue Market Share by Application (2018-2023)
5.3 Global RNA Drugs Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer RNA Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Roche RNA Drugs Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Sanofi-Aventis
6.3.1 Sanofi-Aventis Corporation Information
6.3.2 Sanofi-Aventis Description and Business Overview
6.3.3 Sanofi-Aventis RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi-Aventis RNA Drugs Product Portfolio
6.3.5 Sanofi-Aventis Recent Developments/Updates
6.4 Abbott Laboratories
6.4.1 Abbott Laboratories Corporation Information
6.4.2 Abbott Laboratories Description and Business Overview
6.4.3 Abbott Laboratories RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Abbott Laboratories RNA Drugs Product Portfolio
6.4.5 Abbott Laboratories Recent Developments/Updates
6.5 Arrowhead Pharmaceuticals
6.5.1 Arrowhead Pharmaceuticals Corporation Information
6.5.2 Arrowhead Pharmaceuticals Description and Business Overview
6.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Arrowhead Pharmaceuticals RNA Drugs Product Portfolio
6.5.5 Arrowhead Pharmaceuticals Recent Developments/Updates
6.6 Benitec Biopharma
6.6.1 Benitec Biopharma Corporation Information
6.6.2 Benitec Biopharma Description and Business Overview
6.6.3 Benitec Biopharma RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Benitec Biopharma RNA Drugs Product Portfolio
6.6.5 Benitec Biopharma Recent Developments/Updates
6.7 Calimmune Inc
6.6.1 Calimmune Inc Corporation Information
6.6.2 Calimmune Inc Description and Business Overview
6.6.3 Calimmune Inc RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Calimmune Inc RNA Drugs Product Portfolio
6.7.5 Calimmune Inc Recent Developments/Updates
6.8 Dicerna
6.8.1 Dicerna Corporation Information
6.8.2 Dicerna Description and Business Overview
6.8.3 Dicerna RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Dicerna RNA Drugs Product Portfolio
6.8.5 Dicerna Recent Developments/Updates
6.9 Gradalis
6.9.1 Gradalis Corporation Information
6.9.2 Gradalis Description and Business Overview
6.9.3 Gradalis RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Gradalis RNA Drugs Product Portfolio
6.9.5 Gradalis Recent Developments/Updates
6.10 Quark
6.10.1 Quark Corporation Information
6.10.2 Quark Description and Business Overview
6.10.3 Quark RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Quark RNA Drugs Product Portfolio
6.10.5 Quark Recent Developments/Updates
6.11 RXi
6.11.1 RXi Corporation Information
6.11.2 RXi RNA Drugs Description and Business Overview
6.11.3 RXi RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 RXi RNA Drugs Product Portfolio
6.11.5 RXi Recent Developments/Updates
6.12 Senesco
6.12.1 Senesco Corporation Information
6.12.2 Senesco RNA Drugs Description and Business Overview
6.12.3 Senesco RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Senesco RNA Drugs Product Portfolio
6.12.5 Senesco Recent Developments/Updates
6.13 Silence Therapeutics
6.13.1 Silence Therapeutics Corporation Information
6.13.2 Silence Therapeutics RNA Drugs Description and Business Overview
6.13.3 Silence Therapeutics RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Silence Therapeutics RNA Drugs Product Portfolio
6.13.5 Silence Therapeutics Recent Developments/Updates
6.14 Silenseed
6.14.1 Silenseed Corporation Information
6.14.2 Silenseed RNA Drugs Description and Business Overview
6.14.3 Silenseed RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Silenseed RNA Drugs Product Portfolio
6.14.5 Silenseed Recent Developments/Updates
6.15 Tekmira
6.15.1 Tekmira Corporation Information
6.15.2 Tekmira RNA Drugs Description and Business Overview
6.15.3 Tekmira RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Tekmira RNA Drugs Product Portfolio
6.15.5 Tekmira Recent Developments/Updates
6.16 Alnylam Pharmaceuticals
6.16.1 Alnylam Pharmaceuticals Corporation Information
6.16.2 Alnylam Pharmaceuticals RNA Drugs Description and Business Overview
6.16.3 Alnylam Pharmaceuticals RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Alnylam Pharmaceuticals RNA Drugs Product Portfolio
6.16.5 Alnylam Pharmaceuticals Recent Developments/Updates
7 RNA Drugs Manufacturing Cost Analysis
7.1 RNA Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of RNA Drugs
7.4 RNA Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 RNA Drugs Distributors List
8.3 RNA Drugs Customers
9 RNA Drugs Market Dynamics
9.1 RNA Drugs Industry Trends
9.2 RNA Drugs Market Drivers
9.3 RNA Drugs Market Challenges
9.4 RNA Drugs Market Restraints
10 Global Market Forecast
10.1 RNA Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of RNA Drugs by Type (2023-2030)
10.1.2 Global Forecasted Revenue of RNA Drugs by Type (2023-2030)
10.2 RNA Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of RNA Drugs by Application (2023-2030)
10.2.2 Global Forecasted Revenue of RNA Drugs by Application (2023-2030)
10.3 RNA Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of RNA Drugs by Region (2023-2030)
10.3.2 Global Forecasted Revenue of RNA Drugs by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global RNA Drugs Sales Growth Rate Comparison by Type (2023-2030) & (K Units) & (US$ Million)
Table 2. Global RNA Drugs Sales Growth Rate Comparison by Application (2023-2030) & (K Units) & (US$ Million)
Table 3. Global RNA Drugs Market Size by Region (US$ Million) (2018 VS 2022 VS 2030)
Table 4. Global RNA Drugs Market Competitive Situation by Manufacturers in 2022
Table 5. Global RNA Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 6. Global RNA Drugs Sales Market Share by Manufacturers (2018-2023)
Table 7. Global RNA Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 8. Global RNA Drugs Revenue Share by Manufacturers (2018-2023)
Table 9. Global Market RNA Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 10. Manufacturers RNA Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers RNA Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global RNA Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA Drugs as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global RNA Drugs Sales by Region (2018-2023) & (K Units)
Table 16. Global RNA Drugs Sales Market Share by Region (2018-2023)
Table 17. Global RNA Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 18. Global RNA Drugs Revenue Market Share by Region (2018-2023)
Table 19. North America RNA Drugs Sales by Country (2018-2023) & (K Units)
Table 20. North America RNA Drugs Sales Market Share by Country (2018-2023)
Table 21. North America RNA Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 22. North America RNA Drugs Revenue Market Share by Country (2018-2023)
Table 23. Europe RNA Drugs Sales by Country (2018-2023) & (K Units)
Table 24. Europe RNA Drugs Sales Market Share by Country (2018-2023)
Table 25. Europe RNA Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 26. Europe RNA Drugs Revenue Market Share by Country (2018-2023)
Table 27. Asia Pacific RNA Drugs Sales by Region (2018-2023) & (K Units)
Table 28. Asia Pacific RNA Drugs Sales Market Share by Region (2018-2023)
Table 29. Asia Pacific RNA Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 30. Asia Pacific RNA Drugs Revenue Market Share by Region (2018-2023)
Table 31. Latin America RNA Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Latin America RNA Drugs Sales Market Share by Country (2018-2023)
Table 33. Latin America RNA Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Latin America RNA Drugs Revenue Market Share by Country (2018-2023)
Table 35. Middle East and Africa RNA Drugs Sales by Country (2018-2023) & (K Units)
Table 36. Middle East and Africa RNA Drugs Sales Market Share by Country (2018-2023)
Table 37. Middle East and Africa RNA Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 38. Middle East and Africa RNA Drugs Revenue Market Share by Country (2018-2023)
Table 39. Global RNA Drugs Sales by Type (2018-2023) & (K Units)
Table 40. Global RNA Drugs Sales Market Share by Type (2018-2023)
Table 41. Global RNA Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global RNA Drugs Revenue Share by Type (2018-2023)
Table 43. Global RNA Drugs Price by Type (2018-2023) & (USD/Unit)
Table 44. Global RNA Drugs Sales (K Units) by Application (2018-2023)
Table 45. Global RNA Drugs Sales Market Share by Application (2018-2023)
Table 46. Global RNA Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global RNA Drugs Revenue Share by Application (2018-2023)
Table 48. Global RNA Drugs Price by Application (2018-2023) & (USD/Unit)
Table 49. Pfizer Corporation Information
Table 50. Pfizer Description and Business Overview
Table 51. Pfizer RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 52. Pfizer RNA Drugs Product
Table 53. Pfizer Recent Developments/Updates
Table 54. Roche Corporation Information
Table 55. Roche Description and Business Overview
Table 56. Roche RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 57. Roche RNA Drugs Product
Table 58. Roche Recent Developments/Updates
Table 59. Sanofi-Aventis Corporation Information
Table 60. Sanofi-Aventis Description and Business Overview
Table 61. Sanofi-Aventis RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 62. Sanofi-Aventis RNA Drugs Product
Table 63. Sanofi-Aventis Recent Developments/Updates
Table 64. Abbott Laboratories Corporation Information
Table 65. Abbott Laboratories Description and Business Overview
Table 66. Abbott Laboratories RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 67. Abbott Laboratories RNA Drugs Product
Table 68. Abbott Laboratories Recent Developments/Updates
Table 69. Arrowhead Pharmaceuticals Corporation Information
Table 70. Arrowhead Pharmaceuticals Description and Business Overview
Table 71. Arrowhead Pharmaceuticals RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 72. Arrowhead Pharmaceuticals RNA Drugs Product
Table 73. Arrowhead Pharmaceuticals Recent Developments/Updates
Table 74. Benitec Biopharma Corporation Information
Table 75. Benitec Biopharma Description and Business Overview
Table 76. Benitec Biopharma RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. Benitec Biopharma RNA Drugs Product
Table 78. Benitec Biopharma Recent Developments/Updates
Table 79. Calimmune Inc Corporation Information
Table 80. Calimmune Inc Description and Business Overview
Table 81. Calimmune Inc RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Calimmune Inc RNA Drugs Product
Table 83. Calimmune Inc Recent Developments/Updates
Table 84. Dicerna Corporation Information
Table 85. Dicerna Description and Business Overview
Table 86. Dicerna RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Dicerna RNA Drugs Product
Table 88. Dicerna Recent Developments/Updates
Table 89. Gradalis Corporation Information
Table 90. Gradalis Description and Business Overview
Table 91. Gradalis RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Gradalis RNA Drugs Product
Table 93. Gradalis Recent Developments/Updates
Table 94. Quark Corporation Information
Table 95. Quark Description and Business Overview
Table 96. Quark RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Quark RNA Drugs Product
Table 98. Quark Recent Developments/Updates
Table 99. RXi Corporation Information
Table 100. RXi Description and Business Overview
Table 101. RXi RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. RXi RNA Drugs Product
Table 103. RXi Recent Developments/Updates
Table 104. Senesco Corporation Information
Table 105. Senesco Description and Business Overview
Table 106. Senesco RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Senesco RNA Drugs Product
Table 108. Senesco Recent Developments/Updates
Table 109. Silence Therapeutics Corporation Information
Table 110. Silence Therapeutics Description and Business Overview
Table 111. Silence Therapeutics RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Silence Therapeutics RNA Drugs Product
Table 113. Silence Therapeutics Recent Developments/Updates
Table 114. Silenseed Corporation Information
Table 115. Silenseed Description and Business Overview
Table 116. Silenseed RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Silenseed RNA Drugs Product
Table 118. Silenseed Recent Developments/Updates
Table 119. Tekmira Corporation Information
Table 120. Tekmira Description and Business Overview
Table 121. Tekmira RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Tekmira RNA Drugs Product
Table 123. Tekmira Recent Developments/Updates
Table 124. Alnylam Pharmaceuticals Corporation Information
Table 125. Alnylam Pharmaceuticals Description and Business Overview
Table 126. Alnylam Pharmaceuticals RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Alnylam Pharmaceuticals RNA Drugs Product
Table 128. Alnylam Pharmaceuticals Recent Developments/Updates
Table 129. Production Base and Market Concentration Rate of Raw Material
Table 130. Key Suppliers of Raw Materials
Table 131. RNA Drugs Distributors List
Table 132. RNA Drugs Customers List
Table 133. RNA Drugs Market Trends
Table 134. RNA Drugs Market Drivers
Table 135. RNA Drugs Market Challenges
Table 136. RNA Drugs Market Restraints
Table 137. Global RNA Drugs Sales Forecast by Type (2023-2030) & (K Units)
Table 138. Global RNA Drugs Sales Market Share Forecast by Type (2023-2030)
Table 139. Global RNA Drugs Revenue Forecast by Type (2023-2030) & (US$ Million)
Table 140. Global RNA Drugs Revenue Market Share Forecast by Type (2023-2030)
Table 141. Global RNA Drugs Sales Forecast by Application (2023-2030) & (K Units)
Table 142. Global RNA Drugs Sales Market Share Forecast by Application (2023-2030)
Table 143. Global RNA Drugs Revenue Forecast by Application (2023-2030) & (US$ Million)
Table 144. Global RNA Drugs Revenue Market Share Forecast by Application (2023-2030)
Table 145. Global RNA Drugs Sales Forecast by Region (2023-2030) & (K Units)
Table 146. Global RNA Drugs Sales Market Share Forecast by Region (2023-2030)
Table 147. Global RNA Drugs Revenue Forecast by Region (2023-2030) & (US$ Million)
Table 148. Global RNA Drugs Revenue Market Share Forecast by Region (2023-2030)
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of RNA Drugs
Figure 2. Global RNA Drugs Market Share by Type in 2022 & 2030
Figure 3. siRNA Product Picture
Figure 4. ASO Product Picture
Figure 5. miRNA Product Picture
Figure 6. Nucleic Acid Aptamers Product Picture
Figure 7. Global RNA Drugs Market Share by Application in 2022 & 2030
Figure 8. Cancer
Figure 9. Diabetes
Figure 10. Tuberculosis
Figure 11. Cardiovascular Diseases
Figure 12. Others
Figure 13. Global RNA Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2030
Figure 14. Global RNA Drugs Market Size (2018-2030) & (US$ Million)
Figure 15. Global RNA Drugs Sales (2018-2030) & (K Units)
Figure 16. RNA Drugs Sales Share by Manufacturers in 2022
Figure 17. Global RNA Drugs Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest RNA Drugs Players: Market Share by Revenue in 2022
Figure 19. RNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global RNA Drugs Sales Market Share by Region (2018-2023)
Figure 21. Global RNA Drugs Sales Market Share by Region in 2022
Figure 22. Global RNA Drugs Revenue Market Share by Region (2018-2023)
Figure 23. Global RNA Drugs Revenue Market Share by Region in 2022
Figure 24. U.S. RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 25. Canada RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 26. Germany RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 27. France RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 28. U.K. RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. Italy RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 30. Russia RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 31. China RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 32. Japan RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 33. South Korea RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 34. India RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 35. Australia RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 36. Taiwan RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 37. Indonesia RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 38. Thailand RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 39. Malaysia RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 40. Philippines RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 41. Vietnam RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 42. Mexico RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 43. Brazil RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 44. Argentina RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 45. Turkey RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 46. Saudi Arabia RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 47. U.A.E RNA Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 48. Sales Market Share of RNA Drugs by Type (2018-2023)
Figure 49. Manufacturing Cost Structure of RNA Drugs
Figure 50. Manufacturing Process Analysis of RNA Drugs
Figure 51. RNA Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $2762

Multi User Price : $4143

Enterprise Price : $5524

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global RNA Drugs Market Research Report 2023